Advanced PRAME Positive Solid Tumors
Conditions
Interventions
None listed
Sponsors
T-Knife GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Outcome results
None listed
A study testing a new treatment called TK-6302 for the first time in people with advanced cancers that have a genetic marker called HLA-A02:01 and a tumour protein called PRAME.
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: Feb 28, 2026